Advera Health Analytics Brings Drug Safety Data to the Open:FactSet Marketplace

Share Article

Collaboration will provide critical healthcare information to a broader set of global organizations

Advera Health Analytics, a market leader in cloud based software and data-as-a-service drug safety solutions, today announced the launch of its data on the Open:FactSet Marketplace™ (OFM).

The OFM will feature Advera’s proprietary FDA Adverse Event Reporting System (FAERS) data. FAERS is the U.S. national database containing information on drug adverse events and medication errors voluntarily reported to FDA about marketed drugs. Advera is a market leader in providing optimized and cleansed FAERS data, statistical analysis, and critical workflow tools to pharmaceutical companies, financial institutions, and large healthcare providers.

Advera’s FAERS database contains over 12 million adverse drug event reports, with 1.5 million events reported in 2019 alone. Every adverse drug event report is mapped to the appropriate pharmaceutical company, drug, condition, indication, and mechanism of action and also contains de-identified patient demographic data. Drug label information and statistical calculations of disproportionate reporting are also provided. OFM clients will be able to use Advera’s data in combination with other OFM data sources to power quantitative models for the biopharmaceutical sector.

“Post-marketing adverse event data can be used as a leading indicator for a variety of market triggers”, said Brian Overstreet, President and CEO of Advera Health. “Regulatory authorities and pharmaceutical companies have long used advanced analytics with FAERS data to detect emerging drug safety issues in approved drugs. Our collaboration with FactSet will allow us to not only deliver these data to a broader set of global organizations, but will open opportunities to combine with other OFM datasets to better understand, develop, and refine strategies in the biopharmaceutical sector.”

About Advera Health Analytics
Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Advera Health has created Evidex, a next generation pharmacovigilance platform to connect disparate drug safety data sources and provide a user experience that elicits actionable intelligence from those data. The Evidex platform links to internal ICSR databases, FAERS, VigiBase, and other data and provides for a validated, audit ready environment to track and manage safety issues that are found in those data. Founded by a group of passionate healthcare entrepreneurs, Advera Health’s mission is to mitigate risk in the healthcare system by improving the transparency and actionability of drug safety data through the curation and aggregation of large disparate datasets and the application of advanced analytics and workflow. Please visit http://www.adverahealth.com as well as our newsroom, blog, Twitter, and LinkedIn pages for more information about the company.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brian Overstreet
@AdveraHealth
Follow >
Visit website